Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pro-efferocytic macrophage membrane biomimetic nanoparticles for the synergistic treatment of atherosclerosis via competition effect
Xuan Sha, Yue Dai, Lijuan Chong, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 21

Showing 21 citing articles:

Nanotechnology’s frontier in combatting infectious and inflammatory diseases: prevention and treatment
Yujing Huang, Xiaohan Guo, Yi Wu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 109
Dual-mode-driven nanomotors targeting inflammatory macrophages for the MRI and synergistic treatment of atherosclerosis
Min Wei, Qiaoji Jiang, Shuang Bian, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Nanomedicine for Diagnosis and Treatment of Atherosclerosis
Jingyun Cheng, Hui Huang, Yu Chen, et al.
Advanced Science (2023) Vol. 10, Iss. 36
Open Access | Times Cited: 35
Targeting and repolarizing M2-like tumor-associated macrophage-mediated MR imaging and tumor immunotherapy by biomimetic nanoparticles
Lijuan Chong, Yao‐Wen Jiang, Dongxu Wang, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 21
Macrophage‐Biomimetic Nanoplatform‐Based Therapy for Inflammation‐Associated Diseases
Ying Qu, Bingyang Chu, Jianan Li, et al.
Small Methods (2023) Vol. 8, Iss. 7
Closed Access | Times Cited: 15
Macrophage membrane-mimicking nanoparticles for scavenging reactive oxygen species and modulating immune cells in acute kidney injury treatment
Chenghao Wu, Dongsheng Shen, Zhixiang Bian, et al.
Chemical Engineering Journal (2025), pp. 161135-161135
Closed Access
How Advanced Is Nanomedicine for Atherosclerosis?
Xiang Gu, Lixin Du, Ran Lin, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 3445-3470
Open Access
Nanomedicines for cardiovascular diseases: lessons learned and pathways forward
Yufei Mao, X.F. Shi, Patricia Sun, et al.
Biomaterials (2025), pp. 123271-123271
Closed Access
Liposome-based nanomedicine for immune checkpoint blocking therapy and combinatory cancer therapy
Haoyuan Zhou, Cui‐Yun Yu, Hua Wei
International Journal of Pharmaceutics (2024) Vol. 652, pp. 123818-123818
Closed Access | Times Cited: 4
Biomimetic Nanoparticles for the Diagnosis and Therapy of Atherosclerosis
Yan Wang, Yize Li, Yuqing Lu, et al.
The Chemical Record (2024) Vol. 24, Iss. 9
Closed Access | Times Cited: 4
Macrophage Membrane-Encapsulated Dopamine-Modified Poly Cyclodextrin Multifunctional Biomimetic Nanoparticles for Atherosclerosis Therapy
Li Zhu, Yuan Zhong, Yan Meng, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 25, pp. 32027-32044
Closed Access | Times Cited: 3
Evolocumab loaded Bio-Liposomes for efficient atherosclerosis therapy
Zhenxian Li, Haimei Zhu, Hao Liu, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 8
Novel Metal-Free Nanozyme for Targeted Imaging and Inhibition of Atherosclerosis via Macrophage Autophagy Activation to Prevent Vulnerable Plaque Formation and Rupture
Lingjie Wang, Xiaoqian Zhang, Hongrong Zhang, et al.
ACS Applied Materials & Interfaces (2024)
Open Access | Times Cited: 1
Simultaneously blocking ANGPTL3 and CD47 prevents the progression of atherosclerosis through regulating lipid metabolism, macrophagic efferocytosis and lipid peroxidation
Xiaozhi Hu, Yanyang Nan, Yuting Zhang, et al.
Pharmacological Research (2024) Vol. 210, pp. 107486-107486
Open Access | Times Cited: 1
Enhanced Macrophages Engulfment by Peptide‐Templated Nanoassemblies Targeting SIRPα and Suppressing Oxidative Stress for Atherosclerosis Pro‐Efferocytotic Therapy
Weixi Jiang, Xiaoting Wang, Hongjin An, et al.
Advanced Functional Materials (2024)
Open Access | Times Cited: 1
Effect of nanocapsules containing docosahexaenoic acid in mice with chronic inflammation
Matheus de Castro Leão, I. Piazza, Sarah Jorge Caria, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115474-115474
Open Access | Times Cited: 3
ROS-scavenging anti-inflammatory nucleic acid delivery system for targeted treatment of atherosclerosis
Zunjing Liu, Zihao Liu, Yi Shan, et al.
Nano Today (2023) Vol. 53, pp. 102005-102005
Closed Access | Times Cited: 3
Functional Peptide Hydrogel for the Synergistic Treatment of Atherosclerosis Based on Macrophage Autophagy Induction and Anti-Inflammation
Mengyuan Xing, Shuang Bian, Bangbang Li, et al.
ACS Materials Letters (2023) Vol. 6, Iss. 2, pp. 384-399
Closed Access | Times Cited: 3
The Role of Macrophages in Atherosclerosis: Participants and Therapists
Xiaoyu Liu, Shuchao Pang, Yangyang Jiang, et al.
Cardiovascular Drugs and Therapy (2023)
Closed Access | Times Cited: 2
Beyond cancer: The potential application of CD47-based therapy in non-cancer diseases
Wei-Qing Deng, Zi-Han Ye, Zhenghai Tang, et al.
Acta Pharmaceutica Sinica B (2024)
Open Access
Biomimetic ROS-responsive hyaluronic acid nanoparticles loaded with methotrexate for targeted anti-atherosclerosis
Bingyi Li, Mei He, Zichen Xu, et al.
Regenerative Biomaterials (2024) Vol. 11
Open Access
Developing Cell-Membrane-Associated Liposomes for Liver Diseases
Dongxue Ge, Ran An, Lingling Xue, et al.
ACS Nano (2024) Vol. 18, Iss. 43, pp. 29421-29438
Closed Access
Nano Delivery System for Atherosclerosis
Rong Zhang, Xuan He, T. Y. Fan, et al.
Journal of Functional Biomaterials (2024) Vol. 16, Iss. 1, pp. 2-2
Open Access
Page 1

Scroll to top